AS
VIVO

Altshuler Shaham’s Meridian Bioscience Inc VIVO Stock Holding History

Altshuler Shaham’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,459
Closed -$75K – 554
2022
Q2 		$75K Sell
2,459
-927
-27% -$25.1K ﹤0.01% 189
2022
Q1 		$88K Buy
+3,386
New +$80.5K ﹤0.01% 290
2020
Q4 		– Sell
-1,874
Closed -$32K – 485
2020
Q3 		$32K Buy
1,874
+638
+52% +$12.4K ﹤0.01% 273
2020
Q2 		$29K Buy
+1,236
New +$17.9K ﹤0.01% 231
2019
Q2 		– Sell
-477
Closed -$8K – 404
2019
Q1 		$8K Buy
477
+36
+8% +$599 ﹤0.01% 275
2018
Q4 		$8K Buy
+441
New +$7.52K ﹤0.01% 216

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altshuler Shaham's VIVO Position: Q3 2022 in Review

Altshuler Shaham sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 2,459 shares — an estimated $75K sold.

Altshuler Shaham first reported a position in VIVO in Q4 2018 and held it in 6 quarters. The position peaked at $88K in Q1 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Altshuler Shaham reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Altshuler Shaham sold 2,459 Meridian Bioscience Inc shares in Q3 2022, an estimated $75K.
  • Altshuler Shaham first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 6 quarters.
  • Altshuler Shaham's Meridian Bioscience Inc position peaked at $88K in Q1 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.